40 SUNDAY • MAY 15 103 Immunosuppressant Response Among Individuals Meeting Criteria for Interstitial Pneumonia with Autoimmune Features/J.M. Oldham, A. Adegunsoye, L.J. Witt, E. Valenzi, C.T. Lee, L.W. Chen, S. Hsu, J. Chung, S. Montner, I. Noth, R. Vij, M.E. Strek, Chicago, IL, p.A1136 104 Quantitative CT as an Outcome Measure in the Scleroderma Lung Study II/J.G. Goldin, E. Kleerup, P. Lu, P. Clements, M. Brown, M.D. Roth, D.P. Tashkin, Los Angeles, CA, p.A1133 105 Factors Associated with Relapse of Cryptogenic and Secondary Organizing Pneumonia/Y. Onishi, T. Kawamura, R. Kagami, 8520, Japan, p.A1134 106 Radiological Versus Histological Diagnosis in Antisynthetase -Associated Interstitial Lung Disease/J.A. Huapaya, L.L. Silhan, S.K. Danoff, Baltimore, MD, p.A1135 107 Additional Clinical Signs and Symptoms Develop in Patients with Antisynthetase Syndrome-Associated Interstitial Lung Disease Followed Over 24 Months/J.A. Huapaya, L.L. Silhan, S.K. Danoff, Baltimore, MD, p.A1150 108 Clinico-Radiological-Pathological Characteristics of Idiopathic Pleuroparenchymal Fibroelastosis/K. Gocho, K. Sugino, K. Furuya, Y. Nakamura, T. Isshiki, T. Uekusa, K. Shibuya, S. Homma, Tokyo, Japan, p.A1137 109 Transitional Voxel-Wise Changes in the Interstitial Lung Disease on High Resolution Computed Tomography using Scleroderma Lung Study-II/G.H. Kim, D. Tashkin, P. Lo, P. Lu, M. Brown, E. Kleerup, M.D. Roth, J. Goldin, Los Angeles, CA, p.A1138 110 Clinical Information of Secondary Pulmonary Alveolar Proteinosis in Japan: A Follow-Up Report (KAKEN26305028/AMED:H27-063)/H. Ishii, R. Tazawa, T. Saraya, Y. Inoue, K. Nakata, Mitaka, Japan, p.A1139 111 Short-Term Efficacy of Treatment in Myositis-Associated ILD/M. Hachem, H. Nunes, J. Obert, Y. Uzunhan, D. Valeyre, J. Cadranel, J.-M. Naccache, Paris, France, p.A1140 112 Observational Study of Therapeutic Response to Immunosuppression of CTD-ILD Versus AIF-ILD/R. Parikh, P. Chung, K. Kuchta, R. Vij, S. Bellam, Evanston, IL, p.A1141 113 Pleuroparenchymal Fibroelastosis (PPFE) Predicts Survival in Idiopathic Pulmonary Fibrosis (IPF)/A. De Lauretis, H. Basra, W. Hakim, J. Jacob, D. Visca, M. Kokosi, M. Bonifazi, E. Renzoni, D.M. Hansell, A.U. Wells, London, United Kingdom, p.A1142 114 Lung Cancer in Connective Tissue Disease-Associated Interstitial Lung Disease: Clinical Features and Impact on Outcome/S. Watanabe, Y. Waseda, H. Takato, R. Matsunuma, K. Saeki, J. Hara, T. Sone, M. Abo, H. Kimura, K. Kasahara, Kanazawa, Japan, p.A1143 115 Rheumatoid Arthritis Associated Usual Interstitial Pneumonia: Correlation of Histologic Features with Prognosis/Y. Tsuchiya, D.A. Lynch, T. Johkoh, J. Fukuoka, T. Colby, S. Groshong, H. Taniguchi, K. Ichikado, A. Shiraki, N. Tanaka, H. Arakawa, Y. Waseda, K.K. Brown, J.J. Swigris, J.J. Solomon, Tokyo, Japan, p.A1144 116 Whole Lung Lavage Therapy of Pulmonary Alveolar Proteinosis: A Global Survey of Current Practices and Procedures/I. Campo, M. Luisetti, M. Griese, B.C. Trapnell, F. Bonella, J.C. Grutters, K. Nakata, C.H.M. Van Moorsel, U. Costabel, V. Cottin, T. Ichiwata, Y. Inoue, A. Braschi, G. Bonizzoni, G.A. Iotti, C. Tinelli, G. Rodi, Pavia, Italy, p.A1145 117 Serum Anti-ARS and Anti-MDA-5 Antibodies Are Useful Biomarkers for Predicting the Prognosis in Patients with Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease/H. Hozumi, T. Fujisawa, M. Kono, N. Enomoto, N. Inui, Y. Nakamura, T. Suda, Hamamatsu, Japan, p.A1146 118 Rituximab in Progressive, Refractory to Conventional Treatment, Interstitial Lung Disease/M.A. Kokosi, G. Keir, T. Corte, L. Troy, P. Saunders, F. Chua, T.M. Maher, E. Renzoni, A.U. Wells, London, United Kingdom, p.A1147 119 Comparison of CTD-ILD, Autoimmune Featured ILD, and ILD with a Positive Autoimmune Serologic Marker/P. Chung, R. Parikh, K. Kuchta, R. Vij, S. Bellam, Evanston, IL, p.A1148 120 Acute Fibrinous and Organizing Pneumonia: A Newly Recognized, but Poorly Understood Disease/A. Moraco, E. Bozkurtlar, U. Hironori, A. Akalin, E. Mark, S. Kopec, Worcester, MA, p.A1149 121 Prevalence of Unclassifiable Interstitial Lung Disease (ILD) in a University Hospital in Buenos Aires, Argentina/M.A. Grosso, P. Rossi, G. Legarreta, S. Acuna, J.I. Enghelmayer, Buenos Aires, Argentina, p.A1151 122 Radiographic and Physiologic Abnormalities in Subjects with Myositis-Associated Interstitial Lung Disease/D. Assayag, A. Hirsch, M. Baron, M. Hudson, Montreal, Canada, p.A1152 123 Lung Cancer in Patients with Interstitial Lung Disease: Idiopathic Versus Connective Tissue Disease-Related Subtypes/K. Saeki, S. Watanabe, Y. Waseda, H. Takato, R. Matsunuma, J. Hara, T. Sone, M. Abo, H. Kimura, K. Kasahara, Kanazawa, Japan, p.A1153 124 Idiopathic Pleuroparenchymal Fibroelastosis and Its Mimickers/S. Tomassetti, D.M. Nicotra, J.H. Ryu, S. Piciucchi, A. Dubini, P. Tantalocco, C. Ravaglia, C. Gurioli, A. Rossi, M. Chilosi, G.U. Di Maria, V. Poletti, Forli, Italy, p.A1154 125 Effect of Mycophenolate Mofetil on Scleroderma-associated Interstitial Lung Disease/M. Baqir, A. Makol, T.G. Osborn, B. Bartholmai, J. Ryu, Rochester, MN, p.A1155 A25 POSTER DISCUSSION SESSION CRITICAL CARE: FUNCTIONAL OUTCOMES IN ICU SURVIVORS 9:00 a.m. - 11:00 a.m. MOSCONE CENTER Room 3001 (West Building, Level 3) Poster Viewing 9:00-9:45 Discussion 9:45-11:00 ATS 2016 • San Francisco
SUNDAY • MAY 15 41 Chairing: D.M. Needham, MD, Baltimore, MD R.N. Bakhru, MD, MS, Winston-Salem, NC S.E. Jolley, MD, MSc, New Orleans, LA 701 A Novel Noninvasive Method for Measuring Peripheral Muscle Strength in Fully Sedated Critically Ill Patients/V.M. Da Silva, G. Cipriano Jr, J. Durigan, M. Machado, P.E. Silva, P.F. De Melo, L.T. Urache, Manaus, Brazil, p.A1156 702 Accuracy of the Bedside Swallowing Evaluation and 3-Ounce Water Swallow Test for Diagnosing Aspiration In Survivors of Acute Respiratory Failure/Y. Lynch, B. Clark, H. Taylor, L. Treviso, M. Macht, S.D. White, T. Wimbish, M. Moss, Denver, CO, p.A1157 703 What Are Normal Nerve Conduction Study Amplitudes for Intensive Care Unit Patients?/D.A. Kelmenson, D. Quan, M. Moss, Aurora, CO, p.A1158 704 Physical Function Differs Among Intensive Care Unit Patients with Critical Illness Polyneuromyopathy, Deconditioning and Normal Strength/D.A. Kelmenson, D. Quan, M. Moss, Aurora, CO, p.A1159 705 Application of a Practice Assessment Tool for Rehabilitation of Critically Ill Patients/J.T. Ellison, W.D. Schweickert, K. Kellner, B. Mirafuente, P. Morris, D.C. Files, R.N. Bakhru, Winston Salem, NC, p.A1160 706 Effect of Daily Use of Electronic Checklist on Physical Rehabilitation Consultations in Critically Ill Patients/R. Ali, V. Herasevich, O. Gajic, R. Kashyap, Rochester, MN, p.A1161 707 Impact of Age and ICU Mobility Scores on Healthcare Outcomes/A.M. Pastva, S. Silva, V. Sabol, Durham, NC, p.A1162 708 Development of a Medical Record-Derived Frailty Index for ICU Patients/E.J. Luxenberg, A.A. Hope, M.N. Gong, S.J. Hsieh, Bronx, NY, p.A1163 709 “PERME Intensive Care Unit Mobility Score” e “Intensive Care Unit Mobility Scale (IMS)”: Cross Cultural Validation and Reliability of the Portuguese Version/Y.M.F. Kawaguchi, T.F. Borghetti, R.K. Nawa, L.C. Martins, R.C. Pires-Neto, Sao Paulo, Brazil, p.A1164 710 A Prognostic Model to Predict Disability Free Survival One Year and Five Years After Mechanical Ventilation: A Population Based Cohort Study/M. Wilson, K. Heise, T. Loftsgard, M.A. Dziadzko, K. sarvottam, P. Novotny, O. Gajic, M. Biehl, Rochester, MN, p.A1165 711 Burden of Comorbid Illness Is Associated with 1-Year Survival but Not Early Disability After Critical Illness: Results from the RECOVER <strong>Program</strong>/E. Merman, L. Chu, P. Robles, G. Tomlinson, C. Thomas, S.B. Burns, A. Andrea Matte, A. Matte, J. Friedrich, F. Lamontagne, G.M. Mehta, N. Adhikari, N. Ferguson, J. Rudkowski, H. Meggison, Y. Skrobik, J. Flannery, M. Bayley, J. Batt, C. Dos Santos, D. Cook, J. Cameron, M.S. Herridge, Toronto, Canada, p.A1166 712 Protocolized Simple Bed-Side Rehabilitation for Patients in Intensive Care Unit/S. Park, S. Kim, M. Lee, R. Ko, Y. Choe, S.R. Kim, Y. Lee, H. Lee, Jeonju, Korea, Republic of, p.A1167 713 Early Progressive Mobility Protocol Implementation in the Surgical Intensive Care Unit: Analysis of Medical and Fiscal Benefits/S. Yalamuri, C. Brudney, Durham, NC, p.A1168 714 Characterization of Early Mobilization Practice in a Burn Critical Care Unit/T.B. Figueiredo, K.F. Utsunomiya, R.C. Pires-Neto, Sao Paulo, Brazil, p.A1169 715 Prospective Analysis of Levels of Activity and Functional Decline in Intensive Care Unit/T.T. Gomes, D.S. Schujmann, A.C. Lunardi, C. Fu, Sao Paulo, Brazil, p.A1170 716 The Early Neurocognitive Rehabilitation: Feasibility and Safety in Critically Ill Patients/S. Fernandez-Gonzalo, M. Turon, G. Goma, M. Martinez-Perez, C. De Haro, J. Montanya, M. Jodar, J. Lopez-Aguilar, L. Blanch, Sabadell, Spain, p.A1171 717 Identifying Clinically Important Outcomes in Clinical Trials of Neuromuscular Electrical Stimulation (NMES) in the ICU: A Survey of Key Stakeholders/M.E. Kho, M. Duffett, M.S. Herridge, D.M. Needham, K.K. Koo, F. Lamontagne, P.M. Dodek, F.A. Costigan, D. Cook, Hamilton, Canada, p.A1172 718 A Systematic Review of Clinically Important Outcomes in Clinical Trials of Neuromuscular Electrical Stimulation (NMES) in the ICU: Preliminary Results/M.E. Kho, M. Duffett, D.M. Needham, M.S. Herridge, K.K. Koo, F. Lamontagne, P.M. Dodek, F.A. Costigan, D. Cook, Hamilton, Canada, p.A1173 719 How Important Is the Functional Rehabilitation of Critically Ill Patients with Pulmonary Sepsis in the Hospital Context?/Y.R. De Souza, D.L. Coelho, I.A. Fernandes, B.G. Almeida, V.S. Carvalho, V.H.B.P. Victorio, T.G.B. Melquiades, D.R. Teixeira, B.P. Rosa, C. Rachid, D.R. Oliveira, G. Pinheiro, S. Gomes, J.C. Rodrigues, S.F. Carvalho, Rio de Janeiro, Brazil, p.A1174 720 Maximum Mobility Achieved Among Older Vs. Younger Patients in an Early Mobilization <strong>Program</strong> in the MICU/L.E. Ferrante, T. Gill, T. Murphy, M. Douglas, M. Pisani, New Haven, CT, p.A1175 721 Long-Term Cognitive Outcomes of Mechanically Ventilated Patients in a Randomized Controlled Trial of Early Mobilization/E. MacKenzie, B.K. Patel, K.S. Wolfe, A.S. Pohlman, J.B. Hall, J.P. Kress, Chicago, IL, p.A1176 722 Degree of Physical Impairment and Patient Age Influence Trajectory of Physical Functional Recovery in Survivors of Acute Respiratory Failure/A. Neumeier, A. Nordon-Craft, D. Malone, M. Schenkman, B. Clark, M. Moss, Aurora, CO, p.A1177 723 Mobility and Clinical Characteristics as Predictor and Protective Factors of Functional Decline in the Intensive Care Unit/D.S. Schujmann, T.T. Gomes, A.C. Lunardi, C. Fu, Sao Paulo, Brazil, p.A1178 724 Defining ICU Early Mobility as Walking: An Achievable Activity for Critically Ill Patients/H. Engel, San Francisco, CA, p.A1179 725 Recovery After ICU in Australia: Interim Results of Disability and Cognitive Dysfunction in Survivors at 6 Months/C. Hodgson, T.J. Iwashyna, D.J. Cooper, T. ICU Recovery Study Investigators, Melbourne, Australia, p.A1180 SUNDAY MORNING ATS 2016 • San Francisco
- Page 1 and 2: American Thoracic Society Internati
- Page 3: TABLE OF CONTENTS ATS 2016 INTERNAT
- Page 6 and 7: 2 FRIDAY • MAY 13 PG2A CLINICAL P
- Page 8 and 9: 4 FRIDAY • MAY 13 Target Audience
- Page 10 and 11: 6 FRIDAY • MAY 13 11:15 Case Disc
- Page 12 and 13: 8 FRIDAY • MAY 13 Chairing: H.B.
- Page 14 and 15: 10 FRIDAY • MAY 13 10:25 Advanced
- Page 16 and 17: 12 FRIDAY • MAY 13 Objectives At
- Page 18 and 19: 14 SATURDAY • MAY 14 Abdominal Ul
- Page 20 and 21: 16 SATURDAY • MAY 14 PG17 BASIC
- Page 22 and 23: 18 SATURDAY • MAY 14 1:05 In What
- Page 24 and 25: 20 SATURDAY • MAY 14 10:30 Practi
- Page 26 and 27: 22 SATURDAY • MAY 14 Objectives A
- Page 28 and 29: 24 SATURDAY • MAY 14 10:10 Is My
- Page 30 and 31: 26 SUNDAY • MAY 15 Chairing: D.M.
- Page 32 and 33: 28 SUNDAY • MAY 15 Chronic Cough:
- Page 34 and 35: 30 SUNDAY • MAY 15 • understand
- Page 36 and 37: 32 SUNDAY • MAY 15 Target Audienc
- Page 38 and 39: 34 SUNDAY • MAY 15 Oral Presentat
- Page 40 and 41: 36 SUNDAY • MAY 15 9:15 Hyperpola
- Page 42 and 43: 38 SUNDAY • MAY 15 310 A Smartpho
- Page 46 and 47: 42 SUNDAY • MAY 15 A26 POSTER DIS
- Page 48 and 49: 44 SUNDAY • MAY 15 822 Incidence
- Page 50 and 51: 46 SUNDAY • MAY 15 519 Maternal H
- Page 52 and 53: 48 SUNDAY • MAY 15 P14 P15 P16 P1
- Page 54 and 55: 50 SUNDAY • MAY 15 P1545 P1546 Fa
- Page 56 and 57: 52 SUNDAY • MAY 15 P60 P61 Facili
- Page 58 and 59: 54 SUNDAY • MAY 15 P149 P150 Faci
- Page 60 and 61: 56 SUNDAY • MAY 15 P749 P750 P751
- Page 62 and 63: 58 SUNDAY • MAY 15 Facilitator: P
- Page 64 and 65: 60 SUNDAY • MAY 15 P1243 P1244 P1
- Page 66 and 67: 62 SUNDAY • MAY 15 P1295 P1296 P1
- Page 68 and 69: 64 SUNDAY • MAY 15 P1358 P1359 P1
- Page 70 and 71: 66 SUNDAY • MAY 15 P91 Facilitato
- Page 72 and 73: 68 SUNDAY • MAY 15 P616 P617 P618
- Page 74 and 75: 70 SUNDAY • MAY 15 P914 P915 P916
- Page 76 and 77: 72 SUNDAY • MAY 15 P556 P557 P558
- Page 78 and 79: 74 SUNDAY • MAY 15 Facilitators:
- Page 80 and 81: 76 SUNDAY • MAY 15 P997 P998 P999
- Page 82 and 83: 78 SUNDAY • MAY 15 P256 P257 P258
- Page 84 and 85: 80 SUNDAY • MAY 15 A61 THEMATIC P
- Page 86 and 87: 82 SUNDAY • MAY 15 P824 Facilitat
- Page 88 and 89: 84 SUNDAY • MAY 15 P1055 P1056 P1
- Page 90 and 91: 86 SUNDAY • MAY 15 P1101 P1102 P1
- Page 92 and 93: 88 SUNDAY • MAY 15 P1423 P1424 P1
- Page 94 and 95:
90 SUNDAY • MAY 15 P1474 P1475 P1
- Page 96 and 97:
92 SUNDAY • MAY 15 P377 P378 P379
- Page 98 and 99:
94 SUNDAY • MAY 15 P281 P282 P283
- Page 100 and 101:
96 SUNDAY • MAY 15 P450 P451 A74
- Page 102 and 103:
98 SUNDAY • MAY 15 P1562 P1563 P1
- Page 104 and 105:
100 SUNDAY • MAY 15 A80-A THEMATI
- Page 106 and 107:
102 SUNDAY • MAY 15 Facilitator:
- Page 108 and 109:
104 SUNDAY • MAY 15 11:00 a.m.-12
- Page 110 and 111:
106 SUNDAY • MAY 15 L1 U.S. FOOD
- Page 112 and 113:
108 SUNDAY • MAY 15 12:15 Post-Pr
- Page 114 and 115:
110 SUNDAY • MAY 15 MP406 MP407 M
- Page 116 and 117:
112 SUNDAY • MAY 15 clinician and
- Page 118 and 119:
114 SUNDAY • MAY 15 A86 BASIC •
- Page 120 and 121:
116 SUNDAY • MAY 15 Chairing: M.J
- Page 122 and 123:
118 SUNDAY • MAY 15 3:30 High Pre
- Page 124 and 125:
120 SUNDAY • MAY 15 102 Toll-Like
- Page 126 and 127:
122 SUNDAY • MAY 15 A103 POSTER D
- Page 128 and 129:
124 SUNDAY • MAY 15 719 Lactate R
- Page 130 and 131:
126 SUNDAY • MAY 15 1014 Determin
- Page 132 and 133:
128 SUNDAY • MAY 15 611 Plasma Mi
- Page 134 and 135:
130 SUNDAY • MAY 15 412 Daytime S
- Page 136 and 137:
132 SUNDAY • MAY 15 6:30 p.m. - 8
- Page 138 and 139:
134 MONDAY • MAY 16 SS111 SS112 S
- Page 140 and 141:
136 MONDAY • MAY 16 Target Audien
- Page 142 and 143:
138 MONDAY • MAY 16 9:40 Empoweri
- Page 144 and 145:
140 MONDAY • MAY 16 9:28 Endotoxi
- Page 146 and 147:
142 MONDAY • MAY 16 10:15 Adaptiv
- Page 148 and 149:
144 MONDAY • MAY 16 Oral Presenta
- Page 150 and 151:
146 MONDAY • MAY 16 624 Neonatal
- Page 152 and 153:
148 MONDAY • MAY 16 118 Compariso
- Page 154 and 155:
150 MONDAY • MAY 16 912 Should Pa
- Page 156 and 157:
152 MONDAY • MAY 16 1015 Resverat
- Page 158 and 159:
154 MONDAY • MAY 16 718 Health Re
- Page 160 and 161:
156 MONDAY • MAY 16 P152 Facilita
- Page 162 and 163:
158 MONDAY • MAY 16 B35 THEMATIC
- Page 164 and 165:
160 MONDAY • MAY 16 P252 P253 P25
- Page 166 and 167:
162 MONDAY • MAY 16 P406 P407 P40
- Page 168 and 169:
164 MONDAY • MAY 16 P320 Bilatera
- Page 170 and 171:
166 MONDAY • MAY 16 B40 THEMATIC
- Page 172 and 173:
168 MONDAY • MAY 16 P528 P529 Fac
- Page 174 and 175:
170 MONDAY • MAY 16 Facilitator:
- Page 176 and 177:
172 MONDAY • MAY 16 B44 THEMATIC
- Page 178 and 179:
174 MONDAY • MAY 16 P484 P485 P48
- Page 180 and 181:
176 MONDAY • MAY 16 P1161 P1162 P
- Page 182 and 183:
178 MONDAY • MAY 16 B48 THEMATIC
- Page 184 and 185:
180 MONDAY • MAY 16 P1238 P1239 P
- Page 186 and 187:
182 MONDAY • MAY 16 P1297 P1298 P
- Page 188 and 189:
184 MONDAY • MAY 16 Facilitator:
- Page 190 and 191:
186 MONDAY • MAY 16 P15 P16 P17 P
- Page 192 and 193:
188 MONDAY • MAY 16 Facilitator:
- Page 194 and 195:
190 MONDAY • MAY 16 P114 P115 P11
- Page 196 and 197:
192 MONDAY • MAY 16 P1408 Enhance
- Page 198 and 199:
194 MONDAY • MAY 16 P1455 P1456 P
- Page 200 and 201:
196 MONDAY • MAY 16 P1487 P1488 P
- Page 202 and 203:
198 MONDAY • MAY 16 P1514 P1515 P
- Page 204 and 205:
200 MONDAY • MAY 16 Facilitator:
- Page 206 and 207:
202 MONDAY • MAY 16 P559 P560 P56
- Page 208 and 209:
204 MONDAY • MAY 16 WS3 CLINICAL
- Page 210 and 211:
206 MONDAY • MAY 16 Satellite ear
- Page 212 and 213:
208 MONDAY • MAY 16 Objectives At
- Page 214 and 215:
210 MONDAY • MAY 16 encourage tra
- Page 216 and 217:
212 MONDAY • MAY 16 B82 BEHAVIORA
- Page 218 and 219:
214 MONDAY • MAY 16 B86 BASIC •
- Page 220 and 221:
216 MONDAY • MAY 16 and a number
- Page 222 and 223:
218 MONDAY • MAY 16 2:30 Mortalit
- Page 224 and 225:
220 MONDAY • MAY 16 3:00 Simultan
- Page 226 and 227:
222 MONDAY • MAY 16 525 Clinical
- Page 228 and 229:
224 MONDAY • MAY 16 320 Sensitivi
- Page 230 and 231:
226 MONDAY • MAY 16 113 COPD Subt
- Page 232 and 233:
228 MONDAY • MAY 16 1004 Health C
- Page 234 and 235:
230 MONDAY • MAY 16 609 Skeletal
- Page 236 and 237:
232 MONDAY • MAY 16 5:00 p.m. - 7
- Page 238 and 239:
234 TUESDAY • MAY 17 Chairing: D.
- Page 240 and 241:
236 TUESDAY • MAY 17 CLINICAL YEA
- Page 242 and 243:
238 TUESDAY • MAY 17 This session
- Page 244 and 245:
240 TUESDAY • MAY 17 bronchiectas
- Page 246 and 247:
242 TUESDAY • MAY 17 Target Audie
- Page 248 and 249:
244 TUESDAY • MAY 17 C18 MINI SYM
- Page 250 and 251:
246 TUESDAY • MAY 17 415 Investig
- Page 252 and 253:
248 TUESDAY • MAY 17 207 Survival
- Page 254 and 255:
250 TUESDAY • MAY 17 906 Phenotyp
- Page 256 and 257:
252 TUESDAY • MAY 17 807 The Vali
- Page 258 and 259:
254 TUESDAY • MAY 17 515 Roles of
- Page 260 and 261:
256 TUESDAY • MAY 17 P383 P384 P3
- Page 262 and 263:
258 TUESDAY • MAY 17 Facilitator:
- Page 264 and 265:
260 TUESDAY • MAY 17 P199 P200 P2
- Page 266 and 267:
262 TUESDAY • MAY 17 P620 Facilit
- Page 268 and 269:
264 TUESDAY • MAY 17 P428 P429 P4
- Page 270 and 271:
266 TUESDAY • MAY 17 P442 P443 P4
- Page 272 and 273:
268 TUESDAY • MAY 17 P318 P319 P3
- Page 274 and 275:
270 TUESDAY • MAY 17 P474 P475 Fa
- Page 276 and 277:
272 TUESDAY • MAY 17 Facilitator:
- Page 278 and 279:
274 TUESDAY • MAY 17 P727 P728 P7
- Page 280 and 281:
276 TUESDAY • MAY 17 P774 P775 Fa
- Page 282 and 283:
278 TUESDAY • MAY 17 C53 THEMATIC
- Page 284 and 285:
280 TUESDAY • MAY 17 C55 THEMATIC
- Page 286 and 287:
282 TUESDAY • MAY 17 P1095 P1096
- Page 288 and 289:
284 TUESDAY • MAY 17 P1167 P1168
- Page 290 and 291:
286 TUESDAY • MAY 17 P632 P633 P6
- Page 292 and 293:
288 TUESDAY • MAY 17 P546 P547 P5
- Page 294 and 295:
290 TUESDAY • MAY 17 Facilitator:
- Page 296 and 297:
292 TUESDAY • MAY 17 C65 THEMATIC
- Page 298 and 299:
294 TUESDAY • MAY 17 P659 P660 P6
- Page 300 and 301:
296 TUESDAY • MAY 17 P1506 P1507
- Page 302 and 303:
298 TUESDAY • MAY 17 C70 THEMATIC
- Page 304 and 305:
300 TUESDAY • MAY 17 P1363 P1364
- Page 306 and 307:
302 TUESDAY • MAY 17 P928 P929 P9
- Page 308 and 309:
304 TUESDAY • MAY 17 P973 P974 Fa
- Page 310 and 311:
306 TUESDAY • MAY 17 Facilitator:
- Page 312 and 313:
308 TUESDAY • MAY 17 C80 THEMATIC
- Page 314 and 315:
310 TUESDAY • MAY 17 P98 P99 P100
- Page 316 and 317:
312 TUESDAY • MAY 17 • become a
- Page 318 and 319:
314 TUESDAY • MAY 17 The topics a
- Page 320 and 321:
316 TUESDAY • MAY 17 C85 BASIC
- Page 322 and 323:
318 TUESDAY • MAY 17 C89 BASIC
- Page 324 and 325:
320 TUESDAY • MAY 17 3:20 Pediatr
- Page 326 and 327:
322 TUESDAY • MAY 17 2:45 Long-Te
- Page 328 and 329:
324 TUESDAY • MAY 17 918 Sarcoido
- Page 330 and 331:
326 TUESDAY • MAY 17 410 Effectiv
- Page 332 and 333:
328 TUESDAY • MAY 17 710 Follista
- Page 334 and 335:
330 TUESDAY • MAY 17 509 A Mechan
- Page 336 and 337:
332 TUESDAY • MAY 17 806 Upper Ai
- Page 338 and 339:
334 WEDNESDAY • MAY 18 6:45 Acute
- Page 340 and 341:
336 WEDNESDAY • MAY 18 CLINICAL Y
- Page 342 and 343:
338 WEDNESDAY • MAY 18 Objectives
- Page 344 and 345:
340 WEDNESDAY • MAY 18 D9 BASIC
- Page 346 and 347:
342 WEDNESDAY • MAY 18 Oral Prese
- Page 348 and 349:
344 WEDNESDAY • MAY 18 10:15 Plas
- Page 350 and 351:
346 WEDNESDAY • MAY 18 419 A Nove
- Page 352 and 353:
348 WEDNESDAY • MAY 18 216 Simpli
- Page 354 and 355:
350 WEDNESDAY • MAY 18 815 Multip
- Page 356 and 357:
352 WEDNESDAY • MAY 18 D28 POSTER
- Page 358 and 359:
354 WEDNESDAY • MAY 18 720 Repeat
- Page 360 and 361:
356 WEDNESDAY • MAY 18 P389 Facil
- Page 362 and 363:
358 WEDNESDAY • MAY 18 P439 P440
- Page 364 and 365:
360 WEDNESDAY • MAY 18 P10 P11 P1
- Page 366 and 367:
362 WEDNESDAY • MAY 18 P52 P53 Fa
- Page 368 and 369:
364 WEDNESDAY • MAY 18 P95 P96 P9
- Page 370 and 371:
366 WEDNESDAY • MAY 18 P698 P699
- Page 372 and 373:
368 WEDNESDAY • MAY 18 D42 THEMAT
- Page 374 and 375:
370 WEDNESDAY • MAY 18 P748 Funge
- Page 376 and 377:
372 WEDNESDAY • MAY 18 P353 P354
- Page 378 and 379:
374 WEDNESDAY • MAY 18 P172 P173
- Page 380 and 381:
376 WEDNESDAY • MAY 18 P808 Facil
- Page 382 and 383:
378 WEDNESDAY • MAY 18 P526 P527
- Page 384 and 385:
380 WEDNESDAY • MAY 18 P579 P580
- Page 386 and 387:
382 WEDNESDAY • MAY 18 P944 P945
- Page 388 and 389:
384 WEDNESDAY • MAY 18 P991 P992
- Page 390 and 391:
386 WEDNESDAY • MAY 18 P1036 P103
- Page 392 and 393:
388 WEDNESDAY • MAY 18 P1062 P106
- Page 394 and 395:
390 WEDNESDAY • MAY 18 11:45 Intr
- Page 396 and 397:
392 WEDNESDAY • MAY 18 12:15 Upda
- Page 398 and 399:
394 WEDNESDAY • MAY 18 This sessi
- Page 400 and 401:
396 WEDNESDAY • MAY 18 1:30 The B
- Page 402 and 403:
398 WEDNESDAY • MAY 18 D88 BEHAVI
- Page 404 and 405:
400 WEDNESDAY • MAY 18 3:00 Accel
- Page 406 and 407:
402 WEDNESDAY • MAY 18 D96 MINI S
- Page 408 and 409:
404 WEDNESDAY • MAY 18 604 CARMA3
- Page 410 and 411:
406 WEDNESDAY • MAY 18 702 Potent
- Page 412 and 413:
408 WEDNESDAY • MAY 18 803 ICU Ac
- Page 414 and 415:
410 WEDNESDAY • MAY 18 Chairing:
- Page 416 and 417:
412 WEDNESDAY • MAY 18 404 Interm
- Page 418:
Where today’s science meets tomor